News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Adrian Lee: Altered estrogen disposition and immune signals in the TME of breast cancers in older women
Adrian Lee/LinkedIn
Nov 6, 2024, 11:20

Adrian Lee: Altered estrogen disposition and immune signals in the TME of breast cancers in older women

Adrian Lee, Professor at UPMC Hillman Cancer Center, shared on X:

“Out on bioRxiv our study by Neil Carleton and the Lee-Oesterreich lab/collaborators on altered estrogen disposition and immune/inflammatory signals in the TME of breast cancers in older women.”

Adrian Lee

Systemic and local chronic inflammation and hormone disposition promote a tumor-permissive environment for breast cancer in older women.

Authors: Neil Carleton, Sanghoon Lee, Ruxuan Li, Jian Zou, Daniel D Brown, Jagmohan Hooda, Alexander Chang, Rahul Kumar, Linda R Klei, Lora H Rigatti, Joseph Newsome, Dixcy Jaba Sheeba John Mary, Jennifer M Atkinson, Raymond E West III, Thomas D Nolin, Patrick J Oberly, Ziyu Huang, Donald Poirier, Emilia J Diego, Peter C Lucas, George Tseng, Michael T Lotze, Priscilla F McAuliffe, Ioannis K Zervantonakis, Steffi Oesterreich, Adrian V Lee

Adrian Lee

Adrian Lee Adrian V Lee Alexander Chang bioRxiv cancer Daniel D Brown Dixcy Jaba Sheeba John Mary Donald Poirier Emilia J Diego estrogen disposition George Tseng Ioannis K Zervantonakis Jagmohan Hooda Jennifer M Atkinson Jian Zou Joseph Newsome Lee-Oesterreich lab Linda R Klei Lora H Rigatti Michael T Lotze Neil Carleton OncoDaily Oncology Patrick J Oberly Peter C. Lucas Priscilla F McAuliffe Rahul Kumar Raymond E West III Ruxuan Li Sanghoon Lee Steffi Oesterreich Thomas D Nolin Ziyu Huang
Special Coverage
Insight
Nov 6, 2024, 11:20
Adrian Lee: Altered estrogen disposition and immune signals in the TME of breast cancers in older women
Blog
Nov 6, 2024, 11:03
Nelson Dusetti: Discussing Advancements and foster Argentina-France collaborations in pancreatic cancer research
Blog
Nov 6, 2024, 10:20
Paolo Tarantino: Live discussion on the evolving role of ADCs across tumor histologies
Opinion
Nov 6, 2024, 10:19
Win CIPP accepting applications for Cohort 4 - Winn Awards
Blog
Nov 6, 2024, 10:18
Kimryn Rathmell: Modernizing informed consent for clinical studies
Opinion
Nov 6, 2024, 07:44
Siavash Es'haghi: The white lung cancer ribbon is more than a symbol
Blog
Nov 6, 2024, 07:38
Francisco Cartujano-Barrera: It is feasible to recruit Latinos for a lung cancer screening study through My Chart
Blog
Nov 6, 2024, 07:36
Sendurai Mani: 2024 Blavatnik Family Fellows in Biology and Medicine Named
Blog
Nov 6, 2024, 06:54
Robin Zon: Meeting old friends and make new ones at Reno Nevada
Opinion
Nov 6, 2024, 06:12
A Turning Point in Cancer Treatment?
Blog
Nov 5, 2024, 23:50
Mamtha Balla: Valuable information for oncologists and providers dealing with immunocompromised patients
Blog
Nov 5, 2024, 23:44
Joshua Omale: Accelerating Nigeria's Path to Comprehensive Cancer Control